GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 41 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $795,000 | +248.7% | 635,802 | +223.7% | 0.00% | – |
| Q4 2021 | $228,000 | -68.6% | 196,433 | -47.9% | 0.00% | – |
| Q3 2021 | $725,000 | +8.4% | 377,345 | +31.9% | 0.00% | – |
| Q2 2021 | $669,000 | -5.8% | 286,041 | +9.2% | 0.00% | -100.0% |
| Q1 2021 | $710,000 | +81.1% | 261,856 | +61.7% | 0.00% | – |
| Q4 2020 | $392,000 | +71.9% | 161,961 | +62.8% | 0.00% | – |
| Q3 2020 | $228,000 | +21.9% | 99,489 | +22.2% | 0.00% | – |
| Q2 2020 | $187,000 | +750.0% | 81,385 | +539.8% | 0.00% | – |
| Q1 2020 | $22,000 | -75.8% | 12,721 | -71.0% | 0.00% | – |
| Q4 2019 | $91,000 | -73.1% | 43,883 | -62.4% | 0.00% | -100.0% |
| Q3 2019 | $338,000 | -55.6% | 116,846 | -39.8% | 0.00% | 0.0% |
| Q2 2019 | $761,000 | – | 194,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |